GR3005682T3 - - Google Patents

Info

Publication number
GR3005682T3
GR3005682T3 GR920402010T GR920402010T GR3005682T3 GR 3005682 T3 GR3005682 T3 GR 3005682T3 GR 920402010 T GR920402010 T GR 920402010T GR 920402010 T GR920402010 T GR 920402010T GR 3005682 T3 GR3005682 T3 GR 3005682T3
Authority
GR
Greece
Prior art keywords
methyl
carbazol
imidazol
solvates
tetrahydro
Prior art date
Application number
GR920402010T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005682T3 publication Critical patent/GR3005682T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Connection Of Batteries Or Terminals (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Saccharide Compounds (AREA)
GR920402010T 1986-12-17 1992-09-10 GR3005682T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630071A GB8630071D0 (en) 1986-12-17 1986-12-17 Medicaments

Publications (1)

Publication Number Publication Date
GR3005682T3 true GR3005682T3 (enExample) 1993-06-07

Family

ID=10609112

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402010T GR3005682T3 (enExample) 1986-12-17 1992-09-10

Country Status (18)

Country Link
US (1) US4835173A (enExample)
EP (1) EP0276559B1 (enExample)
JP (1) JP2732844B2 (enExample)
KR (1) KR880007073A (enExample)
AT (1) ATE79031T1 (enExample)
AU (1) AU608794B2 (enExample)
CY (1) CY1693A (enExample)
DE (1) DE3780940T2 (enExample)
DK (1) DK662787A (enExample)
ES (1) ES2051754T3 (enExample)
GB (1) GB8630071D0 (enExample)
GR (1) GR3005682T3 (enExample)
HK (1) HK36593A (enExample)
IE (1) IE60135B1 (enExample)
IL (1) IL84844A0 (enExample)
NZ (1) NZ222949A (enExample)
PH (1) PH25503A (enExample)
ZA (1) ZA879458B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973594A (en) * 1986-12-17 1990-11-27 Glaxo Group Limited Medicaments
US5246941A (en) 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
US5221687A (en) * 1988-09-01 1993-06-22 Glaxo Group Limited Medicaments
GB8820653D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US5180728A (en) * 1989-09-25 1993-01-19 Fujisawa Pharmaceutical Company, Ltd. Pyrimidoindole derivatives and processes for preparation thereof
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
AU2295792A (en) * 1991-06-26 1993-01-25 Sepracor, Inc. Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
JP2002538102A (ja) 1999-03-01 2002-11-12 セプラコア インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する無呼吸および無呼吸障害の治療方法
MXPA03003761A (es) * 2000-10-30 2003-07-28 Teva Pharma Formas de cristales y solvatos de clorhidrato de ondansetron y procesos para su preparacion.
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
HRP20030631A2 (en) * 2001-01-11 2005-06-30 Teva Pharmaceutical Industries Ltd. An improved process for preparing pure ondansetron hydrocloride dihydrate
AU2003223764A1 (en) * 2002-04-29 2003-11-17 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
WO2003093260A1 (en) * 2002-04-30 2003-11-13 Biogal Gyogyszergyar Rt. Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
HU225885B1 (en) * 2002-10-17 2007-11-28 Richter Gedeon Nyrt Process for producing ondansetron hydrochlorid dihydrate of high purity
EP2186517A4 (en) * 2007-08-08 2010-08-18 Ibanez Juan Jose Legarda USE AND METHODS OF USING A SEROTONIN3 (5-HT3) RECEPTOR ANTAGONIST AND CHLORIDE CHANNEL MODULATOR FOR THE TREATMENT OF DRUG OR DRUG ADDICTION OR DEPENDENCE OR CENTER NERVOUS DISORDERS
BR112020022985A2 (pt) 2018-06-21 2021-02-02 Société des Produits Nestlé S.A. composições e métodos que usam um precursor de nicotinamida adenina dinucleotídeo (nad+) e pelo menos uma cetona ou um precursor de cetona

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN158970B (enExample) * 1981-06-09 1987-02-28 Ici Plc
GB8401888D0 (en) * 1984-01-25 1984-02-29 Glaxo Group Ltd Heterocyclic compounds
IE57809B1 (en) * 1984-01-25 1993-04-21 Glaxo Group Ltd 1,2,3,9-tetrahydro-3-(imidazol-1-ylmethyl)-4h-carbazol-4 one derivatives
EP0201165B1 (en) * 1985-03-14 1994-07-20 Beecham Group Plc Medicaments for the treatment of emesis
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
HU895334D0 (en) * 1986-07-30 1990-01-28 Sandoz Ag Process for the preparation of nasal pharmaceutical compositions

Also Published As

Publication number Publication date
DE3780940T2 (de) 1992-12-24
DK662787A (da) 1988-06-18
ES2051754T3 (es) 1994-07-01
EP0276559B1 (en) 1992-08-05
ZA879458B (en) 1988-11-30
DK662787D0 (da) 1987-12-16
EP0276559A2 (en) 1988-08-03
HK36593A (en) 1993-04-23
AU8261787A (en) 1988-06-23
PH25503A (en) 1991-07-24
ATE79031T1 (de) 1992-08-15
IE873415L (en) 1988-06-17
GB8630071D0 (en) 1987-01-28
US4835173A (en) 1989-05-30
JPS63165314A (ja) 1988-07-08
NZ222949A (en) 1997-06-24
EP0276559A3 (en) 1989-10-18
KR880007073A (ko) 1988-08-26
IL84844A0 (en) 1988-06-30
DE3780940D1 (de) 1992-09-10
AU608794B2 (en) 1991-04-18
CY1693A (en) 1994-01-14
IE60135B1 (en) 1994-06-01
JP2732844B2 (ja) 1998-03-30

Similar Documents

Publication Publication Date Title
GR3005682T3 (enExample)
SE8503680D0 (sv) Indolderivat
MX9707570A (es) Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria.
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
EP0786995A4 (enExample)
OA09194A (en) "Insecticidal treatment and compositions therefor".
IE873414L (en) Medicament for dementia
GR3004252T3 (enExample)
FI896306A7 (fi) Miesten yksinkertainen, pakattu inkontinenssisuojus
DE3567211D1 (en) (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use
AP9200355A0 (en) "Therapeutic agent"
EP0435177A3 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
ZA796789B (en) Novel 3,4-diaza-bicyclo (4.1.0) hept-2-en-5-ones, their preparation, and therapeutic agents containing these compounds
NO921086D0 (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
IE873231L (en) Medicaments
GR74782B (enExample)
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
EP0092386A3 (en) Hydantoin therapeutic agents
ZA874878B (en) Pyran derivatives
NZ223203A (en) Herbicidal compositions containing tetrahydrophthalimides and 1,3,5-triazin-2-yl-urea derivatives
李虎容 et al. OCCLUSAL CONSIDERATION FOR IMPLANTS
FI882378A7 (fi) Tandlaekarens patientstol.
CS310487A1 (en) Connection for amplifier's output stage's transistor operating point adjustment
CS754186A1 (en) Aid for medical instruments' introduction